SCHEMBL29349922

SCHEMBL29349922

Cc1nc(Oc2ccc(-c3ccc(F)cc3)nc2)ccc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ MAP4K4 O95819 1/20 0.38
▸ GRM5 P41594 3/20 0.38
▸ NPC1 O15118 3/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ HSPB1 P04792 1/20 0.36
▸ AURKA O14965 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ NTRK1 P04629 1/20 0.36
▸ LCK P06239 1/20 0.36
▸ CSF1R P07333 1/20 0.36
▸ RET P07949 1/20 0.36
▸ MET P08581 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22529957 1.00 MEN1 (0.43) MEN1KMT2AKDM4EMAP4K4GRM5
SCHEMBL29349924 0.87 CYP11B1 (0.49) MEN1KMT2AMAP4K4GRM5NPC1
SCHEMBL26140408 0.87 MEN1 (0.39) MEN1KMT2AKDM4EMAP4K4GRM5
SCHEMBL22529945 0.87 CYP11B1 (0.49) MEN1KMT2AMAP4K4GRM5NPC1
SCHEMBL22529903 0.85 MEN1 (0.47) MEN1KMT2AKDM4EMAP4K4NPC1
SCHEMBL29351760 0.85 MEN1 (0.47) MEN1KMT2AKDM4EMAP4K4NPC1
SCHEMBL29352030 0.82 AURKA (0.38) MEN1KMT2AKDM4EGRM5NPC1
SCHEMBL22529924 0.82 AURKA (0.38) MEN1KMT2AKDM4EGRM5NPC1
SCHEMBL22529954 0.81 HSPB1 (0.47) MEN1KMT2AKDM4EGRM5NPC1
SCHEMBL29351967 0.81 HSPB1 (0.47) MEN1KMT2AKDM4EGRM5NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118994001-A NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2024-11-22 — — CN disclosed
CN-113966324-B NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2024-09-03 — — CN disclosed
EP-3953335-A1 INHIBITORS OF NOTCH SIGNALLING PATHWAY AND USE THEREOF IN TREATMENT OF CANCERS Cellestia Biotech AG (CH) 2022-02-16 — — EP disclosed
CN-113966324-A NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2022-01-21 — — CN disclosed
Send feedback